We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.25 | -1.35% | 18.25 | 100,026 | 13:05:01 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 18.00 | 18.50 | 18.50 | 18.25 | 18.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Computers | 1.03M | -2.92M | -0.0666 | -2.74 | 8.11M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:27:08 | O | 25,000 | 18.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/12/2024 | 10:56 | UK RNS | Feedback PLC Holding(s) in Company |
| 09/12/2024 | 10:48 | UK RNS | Feedback PLC Holding(s) in Company |
| 04/12/2024 | 07:00 | UK RNS | Feedback PLC Holding(s) in Company |
| 03/12/2024 | 12:33 | UK RNS | Feedback PLC Holding(s) in Company |
| 03/12/2024 | 12:18 | UK RNS | Feedback PLC Holding(s) in Company |
| 02/12/2024 | 11:53 | UK RNS | Feedback PLC Holding(s) in Company |
| 02/12/2024 | 11:46 | UK RNS | Feedback PLC Holding(s) in Company |
| 02/12/2024 | 07:00 | UK RNS | Feedback PLC Director/PDMR Shareholding |
| 29/11/2024 | 15:36 | UK RNS | Feedback PLC Holding(s) in Company |
| 29/11/2024 | 15:33 | UK RNS | Feedback PLC Holding(s) in Company |
Feedback (FDBK) Share Charts1 Year Feedback Chart |
|
1 Month Feedback Chart |
Intraday Feedback Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 10/12/2024 | 15:32 | FEEDBACK plc Medical Imaging Technology | 11,627 |
| 04/11/2019 | 07:39 | Feedback | 35 |
| 01/11/2018 | 15:33 | ****Feedback PLC**** | 3,006 |
| 03/2/2010 | 11:50 | Feedback looks interesting - could easily be a ten bagger over next year | 396 |
| 03/9/2002 | 10:53 | ainsley long .........................quick shart it | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-12-12 16:27:09 | 18.00 | 25,000 | 4,500.00 | O |
| 2024-12-12 15:09:35 | 18.00 | 5,000 | 900.00 | O |
| 2024-12-12 15:07:36 | 18.03 | 5,000 | 901.25 | O |
| 2024-12-12 14:48:41 | 18.10 | 12,500 | 2,262.50 | O |
| 2024-12-12 11:40:51 | 18.75 | 2,500 | 468.75 | O |
| Top Posts |
|---|
Posted at 12/12/2024 08:20 by Feedback Daily Update Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 18.50p.Feedback currently has 43,814,779 shares in issue. The market capitalisation of Feedback is £7,996,197. Feedback has a price to earnings ratio (PE ratio) of -2.74. This morning FDBK shares opened at 18.50p |
Posted at 04/12/2024 15:25 by ged5 I like your enthusiasm James, but several holders here were also here just over three years ago to hear TO say this:-"well we are addressing a total available market in excess of 10 Billion globally, I think that the CDC opportunity is a total addressable market of about 93 Million, here within UK, so a sizable figure, especially considering we are now live with the exemplar site right at the front runner of that, we are … very well positioned for it, and in India with the TB opportunity is enormous" You can read the full transcript in the Sunday Roast given to us by a past poster, Ragnarr. Hope he's doing OK, not heard from him for a long time. There have also been other pieces of over exuberance notably before a fundraise. Some have reduced over the years, in my case quite considerably, because of the false dawns. So forgive us for not being taken in by this latest spiel. I really do hope this comes good but until the contracts start flowing in then I'm afraid this is just a hold for me. But I hope you do well with it. By the way 40+m mkt cap equates to 91p + share price Pedantics I know. Good grief, Yump I thought I was pessimistic about FDBK. You take it to a different level! |
Posted at 04/12/2024 14:38 by yump My finger in the air random prediction comes up with another raise at 10p, in a years time.Thats my most optimistic forecast. It is of course possible that FDBK will get a paid contract for setting up some pilots in pursuit of the theoretical utopian NHS new operational model. Around £20mln would go some way to at least break even on the various raises in the last few years. |
Posted at 03/12/2024 15:56 by ducatiman looks like we have an FDBK ramper, well that's a first.Wonder if he was sent by an institution? |
Posted at 03/12/2024 14:37 by yump “ but we are now in the business end and at the revenue inflection point.”Thats rubbish and a cliche. What has actually happened is that the original business model has failed to gain any financially significant traction. So they’ve changed it and are now dressing it up as kings new clothes, with even grander “potentialR I’m sure it will draw in some more naieve pi’s plus more “serious” Plus a few short term chancers. £5000 at 20p is the same amount to be lost as £5000 at £1 a share. The share price is not a measure of cheapness but I’m sure a lot more punters would like it if it was 1p. If it was £1 a share it would just look more credible, but the business would be the same. If I’d got excited about MOU’s and not sales in my businesses, I would have lost my house. TO and FDBK can afford to be excited about MOU’s because they’re living off my and others’ hard-earned. |
Posted at 02/12/2024 13:13 by ged5 I realise a number of us have become disillusioned with FDBK and are very sceptical about Oakley's pitch and what you've posted does seem to be correct.What I'm looking at is a substantial increase in holding by Cranston, increase by several directors both in the placing and in the market and small purchases by Oakley and Patel. Even Eschauzier has bought back the ones he sold by mistake. Seguro Nominees have reduced but Canaccord have made an initial purchase. Not sure if Charlton has increased or decreased and Hayball hasn't bought any that I can see. If those two have bought some I'd feel more confident about future success for FDBK. Even so it's made me wonder with these director buys and a long standing holder such as Cranston giving further backing whether there is likely to be a change of fortune come April. Let's see if I'm brave/foolish enough to purchase more when I have available funds. |
Posted at 02/12/2024 10:18 by yump You’ll have to second-guess when the vast number of 20p holders will bail then.Unless they say otherwise, the cash is going to be used very quickly, because they’re having to fund each system, with no monetary contract and then hope they get enough patients through to get the per-patient cash. They are also “selling” I may be fed up with FDBK, but those are the facts of the current situation. To be fair, they do have an MOU for a pilot. That must be worth at least erm, well, pick a figure in the billions because it could be a whole new operational model for the NHS, funded by FDBK shareholders. |
Posted at 04/11/2024 07:51 by yump But TO says “there’s no better time to invest in the company”.I guess that’s why the issue price is 20p. I think a few of us thought a placing would be coming because the new amazing collaboration only gets paid per patient. So FDBK have to install Bleepa/Carelocker at their expense and hope enough clinicians use it with patients to make it pay. All the financial risk is now with FDBK. Written off my investment. This will die a long slow death. |
Posted at 16/10/2024 06:40 by yump Sort of good news - perhaps.So ring fenced and diverted capital budgets are supposedly an obstacle. Now there is a fund in revenue spend for diverting patients away from normal outpatient process. That doesn’t answer the question of how many trusts are interested but stuck with the capital spend problem. That is what I want to know. We have never been told that crucial information. It also doesn’t cover the overall process of implementing Bleepa in a location, because its per-patient funding. Can a trust get advance funding for a prospective number of patients, or does FDBK have to carry the implementaion spend/effort before any cash is forthcoming - and that depends on patient flow. So is there a contract committment from a trust ? Without it FDBK will be like a charity and so will shareholders. The fact that they need an implementation partner makes me think they have been useless in getting even committment in principle from more tham a handful of trusts. |
Posted at 28/5/2024 17:17 by ydderf LR2 you had some questions and made assertions about Nimble in the other place. This below should help you with your worries:"Imaging Biometrics, LLC data security statement (2024-05-28): Imaging Biometrics (IB) and its developed software applications (apps) comply with the requirements of the US HIPAA and the EU GDPR regulations. IB applies the principles outlined in the US FDA cybersecurity guidance to all the software apps it develops, whether or not a given app is technically classified as a medical device. IB is evaluating the changes in the newly-released revision 3 of the US NIST share price 800-171r3 standard for integration into its policies, procedures, and software development process. Similarly, IB is pursuing implementation of the recommendations contained in the NIST share price 800-218 secure software development framework and ISO 27001 information security standards. Note IB does not host the data accessed via IB Nimble. All data is hosted by the implementing client institution within its data center and is also subject to the institution’s privacy and information security policies and practices." You're welcome! Perhaps you share with the LSE posters you engaged with recently? You were commenting upon this RNS: |
Posted at 15/11/2022 16:25 by chopper harris1 What the hell wwre they thinking of with the 200:1 consolidation?10:1?, yes, possibly, if they wanted to make some kind of statement which might have taken the FDBK share price a little out of typical penny share territory in the eyes of some. But 200:1? Sheer bloody madness which has almost certainly given most of us very little chance of ever getting our money back. Which clowns gave our hapless FDBK chumps this advice? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
